Re: Deja Vu All Over Again
|
6
|
Resverlogix Corp.
|
Mar 12, 2022 02:20AM
|
Re: December 22, 2020.
|
5
|
Resverlogix Corp.
|
Oct 09, 2020 11:57PM
|
Re: Dec 22
|
3
|
Resverlogix Corp.
|
Nov 10, 2020 01:00PM
|
Re: CTAD Poster
|
5
|
Resverlogix Corp.
|
Nov 05, 2020 12:19AM
|
Re: COVID-19 "competition" to keep an eye on.
|
4
|
Resverlogix Corp.
|
Feb 08, 2021 06:29PM
|
Re: COVID-19 "competition" to keep an eye on.
|
2
|
Resverlogix Corp.
|
Feb 12, 2021 03:22AM
|
Re: COVID-19 "competition" to keep an eye on.
|
3
|
Resverlogix Corp.
|
Feb 09, 2021 03:33PM
|
Re: Covid Update
|
2
|
Resverlogix Corp.
|
Jun 11, 2022 11:02AM
|
Re: Covid opportunity
|
2
|
Resverlogix Corp.
|
Mar 08, 2021 02:36PM
|
Re: Covid opportunity
|
2
|
Resverlogix Corp.
|
Mar 08, 2021 05:56PM
|
Re: Covid opportunity
|
4
|
Resverlogix Corp.
|
Mar 08, 2021 06:41PM
|
Re: Covid and apabetalone
|
13
|
Resverlogix Corp.
|
Oct 20, 2020 11:47PM
|
Re: Covid and apabetalone
|
9
|
Resverlogix Corp.
|
Oct 21, 2020 12:04AM
|
Re: Covid and apabetalone
|
7
|
Resverlogix Corp.
|
Oct 21, 2020 12:26AM
|
Re: COVID 19 - Standard of Care
|
5
|
Resverlogix Corp.
|
Apr 22, 2021 03:36PM
|
Re: COVID 19 - Standard of Care
|
4
|
Resverlogix Corp.
|
Apr 22, 2021 05:49PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
3
|
Resverlogix Corp.
|
Dec 13, 2021 08:59AM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
5
|
Resverlogix Corp.
|
Dec 13, 2021 01:04PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
9
|
Resverlogix Corp.
|
Apr 14, 2021 10:57PM
|
Re: Constellation Pharma
|
4
|
Resverlogix Corp.
|
Jun 29, 2020 03:13PM
|